Search results
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 3 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 3 days agoThe Covid effect not as damaging as feared For its first quarter, Pfizer reported before market open, the pharmaceutical giant took in just under $14.9...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expect
Guru Focus· 4 days agoIts top-selling products include the pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis, with international sales comprising nearly ...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 3 days agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 3 days agoThe revenue decline, as expected, was due to a steep drop in revenues from its COVID-19 products,...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 4 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 2 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID< ...